Leonteq Securities »

Taysha Gene Therapies shares owned by Leonteq Securities

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Leonteq Securities from 13F filings

Historical chart of Leonteq Securities investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Leonteq Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Leonteq Securities

Quarter filed Position value Share count Share price at filing
2025-12-31 $154k 28k 5.50
2025-03-31 $111k 80k 1.39
2024-12-31 $138k 80k 1.73

More positions owned by Leonteq Securities

Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Amazon (AMZN)
Advanced Micro Devices (AMD)
Meta Platforms Cl A Put Option (META)
Alphabet Cap Stk Cl A (GOOGL)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Stellantis SHS (STLA)
Micron Technology (MU)
Tesla Motors Call Option (TSLA)
Microsoft Corporation Put Option (MSFT)
Broadcom Put Option (AVGO)
Taiwan Semiconductor Mfg Sponsored Ads Call Option (TSM)
Citigroup Com New Put Option (C)
Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)

View all positions for Leonteq Securities

Top funds holding Taysha Gene Therapies

RA Capital Management
venBio Select Advisor
BlackRock
Rtw Investments
FMR
Vestal Point Capital
Goldman Sachs Group
Vanguard Group
State Street Corporation
Siren
Octagon Capital Advisors
Polar Capital Holdings
Barclays
Geode Capital Management
Millennium Management

View all funds holding Taysha Gene Therapies